 |
|
A Critical Review of the New Oral CephalosporinsConsiderations and Place in Therapy
Daniel P. Rodman, pharmD;
Jerry T. McKnight, MD;
Russell L. Anderson, MD
Arch Fam Med. 1994;3(11):975-980.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Tomasz A. The mechanism of the irreversible antimicrobial effects of penicillins: how the betalactam antibiotics kill and lyse bacteria. Annu Rev Microbiol. 1979;33:113-137.
PUBMED
2. Rodriquez WJ, Khan W, Sait T, et al. Cefixime vs cefaclor in the treatment of acute otitis media in children: a randomized, comparative study. Pediatr Infect Dis J. 1993;12:70-74.
PUBMED
3. Kiani R, Johnson D, Nelson B. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Am J Med. 1988;85(suppl3A):6-13.
PUBMED
4. Irvani A, Richard G, Johnson D, Bryant A. A doubleblind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of urinary tract infections in adult patients. Am J Med. 1988;85(suppl 3A):17-23.
PUBMED
5. Levenstein J, Summerfield PJF, Fourie S, et al. Comparison of cefixime and cotrimoxazole in acute uncomplicated urinary tract infection: a doubleblind general practice study. S Afr Med J. 1986;70:455-460.
PUBMED
6. Handsfield HH, McCormack MD, Hook EW III, et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. N Engl J Med. 1991;325:1337-1341.
ABSTRACT
7. Aronovitz GH, Doyle CA, Durham SJ, et al. Cefprozil vs amoxicillin/clavulanate in the treatment of acute otitis media. Infect Med. 1992;9 (suppl C):19-32.
8. Poole JM, Rosenberg R, Aronovitz GH, et al. Cefprozil vs cefixime and cefaclor in otitis media in children. Infect Med. 1992;9(suppl E):21-32.
9. Doyle CA, Durham SJ, Hamilton HA, et al. Cefprozil vs cefaclor in the treatment of pharyngitis and tonsillitis in adults. Infect Med. 1992;9 (suppl E):66-67.
10. De la Garza CA, Nolen TM, Rogan MP. Cefprozil vs erythromycin in streptococcal tonsillopharyngitis. Infect Med. 1992;9(suppl E):8-20.
PUBMED
11. Bonnet JP, Ginsberg O, Nolen TM, et al. Cefprozil vs cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on bronchitis. Infect Med. 1992;9(suppl E):48-56.
12. Barbarash RA, Solomon E, Thieneman A Jr, et al. Ceprozil vs amoxicillin/clavulanate in mild to moderate lower respiratory tract infections: a focus on bronchitis. Infect Med. 1992;9(suppl E):40-47.
13. Wachs G, Rogan MP, Cefprozil Multicenter Study Group. Cefprozil vs erythromycin for mild to moderate skin and skin structure infections. Infect Med. 1992;9(suppl E):57-65.
14. Solomon E, McCarty JM, Morman MR, et al. Comparison of cefprozil and amoxicillin/clavulanate potassium in the treatment of skin and skin structure infections in adults. Adv Ther. 1992;9:156-164.
15. Shiba K, Saito A, Shimada J, et al. Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method. Kansenshogaku Zasshi. 1988;62:973-1001.
PUBMED
16. Zuck P, Riol U, lchou F. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia. J Antimicrob Chemother. 1990;26(suppl E):71-77.
FREE FULL TEXT
17. Mendelman PM, Del Beccaro MA, McLinn SE, Todd WM. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. J Pediatr. 1992;121:459-465.
PUBMED
18. Dere WH, Farlow D, Therasse DG, Ruoff GE. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis. Clin Ther. 1992;14:41-53.
PUBMED
19. Hyslop DL, Jacobson K, Guerra FJ. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia. Clin Ther. 1992;14:254-267.
PUBMED
20. Nielsen RW. Acute bacterial maxillary sinusitis: results of US and European comparative trials. Am J Med. 1992;92(suppl 6A):70S-73S.
PUBMED
21. Foshee WS. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion. J Pediatr. 1992;120:980-986.
PUBMED
22. McCarty J. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adult population. Am J Med. 1992;92 (suppl 6A):74S-79S.
PUBMED
23. McCarty J, Ruoff GE, Jacobson KD. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population. Am J Med. 1992;92(suppl6A):80S-85S.
PUBMED
24. Irvani A. Loracarbef versus cefaclor in the treatment of urinary tract infections in women. Antimicrob Agents Chemother. 1991;35:750-752.
FREE FULL TEXT
25. Hyslop DL, Bischoff W. Loracarbef (LY163892) versus cefaclor and norfloxin in the treatment of uncomplicated pyelonephritis. Am J Med. 1992;92(suppl 6A):86S-94S.
PUBMED
26. Red Book. Oradell, NJ: Medical Economics Books; 1994.
|
